References
- Araujo AP, Ribeiro R, Pereira D, et al (2009). Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med, 234, 241-5. https://doi.org/10.3181/0805-RM-146
- Baser E, Togrul C, Ozgu E, et al (2013). Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer. Asian Pac J Cancer Prev, 14, 7635-8. https://doi.org/10.7314/APJCP.2013.14.12.7635
- Cowling VH, D'Cruz CM, Chodosh LA, et al (2007). c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol, 27, 5135-46. https://doi.org/10.1128/MCB.02282-06
- DiMeo TA, Anderson K, Phadke P, et al (2009). A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res, 69, 5364-73. https://doi.org/10.1158/0008-5472.CAN-08-4135
- Fillmore RA, Mitra A, Xi Y, et al (2009). Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer, 125, 556-64. https://doi.org/10.1002/ijc.24276
- Forget MA, Turcotte S, Beauseigle D, et al (2007). The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer, 96, 646-53. https://doi.org/10.1038/sj.bjc.6603579
- Glas AS, Lijmer JG, Prins MH, et al (2003). The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol, 56, 1129-35. https://doi.org/10.1016/S0895-4356(03)00177-X
- Gonzalez-Sancho JM, Aguilera O, Garcia JM, et al (2005). The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene, 24, 1098-103. https://doi.org/10.1038/sj.onc.1208303
- Hall CL, Daignault SD, Shah RB, et al (2008). Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate, 68, 1396-404. https://doi.org/10.1002/pros.20805
- Hirata H, Hinoda Y, Nakajima K, et al (2011). Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer, 128, 1793-803. https://doi.org/10.1002/ijc.25507
- Jiang T, Wang S, Huang L, et al (2009). Clinical significance of serum DKK-1 in patients with gynecological cancer. Int J Gynecol Cancer, 19, 1177-81. https://doi.org/10.1111/IGC.0b013e31819d8b2d
- Kaba M, Pirincci N, Benli E, et al (2014). Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopathological features. Asian Pac J Cancer Prev, 15, 381-4. https://doi.org/10.7314/APJCP.2014.15.1.381
- Katoh Y, Katoh M (2005). Comparative genomics on DKK2 and DKK4 orthologs. Int J Mol Med, 16, 477-81.
- Kuphal S, Lodermeyer S, Bataille F, et al (2006). Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene, 25, 5027-36. https://doi.org/10.1038/sj.onc.1209508
- Lee AY, He B, You L, et al (2004). Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun, 323, 1246-50. https://doi.org/10.1016/j.bbrc.2004.09.001
- Lee HS, Lee HE, Park do J, et al (2012). Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clin Chim Acta, 413, 1753-60. https://doi.org/10.1016/j.cca.2012.07.003
- Liu S, Howell P, Ren S, et al (2009). Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma. Clin Exp Metastasis, 26, 739-49. https://doi.org/10.1007/s10585-009-9273-8
- Ma GJ, Gu RM, Zhu M, et al (2013). Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac J Cancer Prev, 14, 7551-4. https://doi.org/10.7314/APJCP.2013.14.12.7551
- Mikheev AM, Mikheeva SA, Maxwell JP, et al (2008). Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat, 112, 263-73. https://doi.org/10.1007/s10549-007-9867-2
- Mikheev AM, Mikheeva SA, Rostomily R, et al (2007). Dickkopf-1 activates cell death in MDA-MB435 melanoma cells. Biochem Biophys Res Commun, 352, 675-80. https://doi.org/10.1016/j.bbrc.2006.11.079
- Mitra A, Menezes ME, Shevde LA, et al (2010). DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype. J Biol Chem, 285, 24686-94. https://doi.org/10.1074/jbc.M109.094847
- Ogoshi K, Kasamatsu A, Iyoda M, et al (2011). Dickkopf-1 in human oral cancer. Int J Oncol, 39, 329-36.
- Sato N, Yamabuki T, Takano A, et al (2010). Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res, 70, 5326-36. https://doi.org/10.1158/0008-5472.CAN-09-3879
- Shen CH, Hsieh HY, Wang YH, et al (2010). High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. Exp Ther Med, 1, 893-8.
- Shen Q, Fan J, Yang XR, et al (2012). Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol, 13, 817-26. https://doi.org/10.1016/S1470-2045(12)70233-4
- Sheng SL, Huang G, Yu B, et al (2009). Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem, 55, 1656-64. https://doi.org/10.1373/clinchem.2009.125641
- Shi RY, Yang XR, Shen QJ, et al (2013). High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery. Cancer, 119, 993-1003. https://doi.org/10.1002/cncr.27788
- Soydinc HO, Duranyildiz D, Camlica H, et al (2011). Lack of diagnostic potential of Dickkopf-1 in colon and rectum cancers. Asian Pac J Cancer Prev, 12, 3187-9.
- Suzuki R, Onizuka M, Kojima M, et al (2007). Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia. Br J Haematol, 138, 624-31. https://doi.org/10.1111/j.1365-2141.2007.06702.x
- Tung EK, Mak CK, Fatima S, et al (2011). Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int, 31, 1494-504. https://doi.org/10.1111/j.1478-3231.2011.02597.x
- Wang S, Zhang S (2011). Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion. Clin Exp Metastasis, 28, 581-91. https://doi.org/10.1007/s10585-011-9393-9
- Wirths O, Waha A, Weggen S, et al (2003). Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest, 83, 429-34. https://doi.org/10.1097/01.LAB.0000059926.66359.BD
- Yaccoby S, Ling W, Zhan F, et al (2007). Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood, 109, 2106-11. https://doi.org/10.1182/blood-2006-09-047712
- Yamabuki T, Takano A, Hayama S, et al (2007). Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res, 67, 2517-25. https://doi.org/10.1158/0008-5472.CAN-06-3369
Cited by
- L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation vol.14, pp.4, 2017, https://doi.org/10.3892/ol.2017.6693